Endonovo to Donate SofPulse® Units for Investigational Use to Evaluate Inhibition of Inflammatory Symptoms Associated with COVID-19
March 16, 2020 08:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced it will donate SofPulse® devices to Intensive Care Units...